SR Medical Technology Company Limited (HKG:0108)
Hong Kong · Delayed Price · Currency is HKD 1.650
+0.100 (6.45%)
Jul 31, 2026, 4:08 PM HKT
HKG:0108 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -109.63 | -918.5 | -129.31 | -320.13 | 207.63 |
Depreciation & Amortization | 1.18 | 2.08 | 2.41 | 2.88 | 6.99 |
Other Amortization | 0.28 | 0.2 | 0.13 | 0.33 | 0.15 |
Gain (Loss) on Sale of Assets | - | - | - | -3.81 | 48.5 |
Gain (Loss) on Sale of Investments | - | - | - | - | 1.9 |
Asset Writedown | 62.78 | 935 | 316.32 | 395.96 | 50.55 |
Stock-Based Compensation | - | 3.13 | 6.58 | - | - |
Change in Accounts Receivable | 16.5 | 20.98 | -43.58 | -52.69 | -15.85 |
Change in Accounts Payable | 7.54 | 4.03 | -23.67 | 50.59 | 29.03 |
Change in Other Net Operating Assets | 6.27 | 1.39 | 52.13 | -221.89 | -19.13 |
Other Operating Activities | 144.77 | 36.81 | -65.25 | 34.08 | -264.13 |
Net Cash from Discontinued Operations | - | - | - | - | -10.88 |
Operating Cash Flow | 121.78 | 85.49 | 122.57 | -106.36 | 47.59 |
Operating Cash Flow Growth | 42.45% | -30.25% | - | - | 1142.53% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Acquisition of Real Estate Assets | -142.47 | -101.22 | -114.73 | -124.25 | -102.41 |
Sale of Real Estate Assets | - | - | - | - | 0 |
Net Sale / Acq. of Real Estate Assets | -142.47 | -101.22 | -114.73 | -124.25 | -102.4 |
Investment in Marketable & Equity Securities | - | 31.23 | -20.13 | -11.56 | 24.84 |
Other Investing Activities | -70.68 | 73.67 | -173.22 | 0.42 | 5.06 |
Investing Cash Flow | -214.24 | 2.74 | -308.5 | -136.25 | 64.19 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | 28.06 | 59.76 | - | 84.04 | 100.46 |
Long-Term Debt Issued | 581.18 | - | 322.33 | 1,582 | 831.47 |
Total Debt Issued | 609.24 | 59.76 | 322.33 | 1,666 | 931.92 |
Short-Term Debt Repaid | -99.02 | -100.36 | -47.42 | -1,299 | -57.16 |
Long-Term Debt Repaid | -387.46 | -24.61 | -24.33 | -15.91 | -834.16 |
Total Debt Repaid | -486.47 | -124.97 | -71.75 | -1,314 | -891.32 |
Net Debt Issued (Repaid) | 122.77 | -65.21 | 250.58 | 351.88 | 40.61 |
Other Financing Activities | -108.49 | -133.92 | -114.21 | -77.42 | -84.35 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 6.26 | -1.5 | 5.95 | 13.27 | 1.49 |
Net Cash Flow | -71.93 | -112.41 | -43.63 | 45.13 | 69.52 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Levered Free Cash Flow | -97.97 | 19.15 | 181.97 | -14.57 | 499.32 |
Unlevered Free Cash Flow | -1.95 | 108.59 | 262.67 | 70.71 | 566.87 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 108.49 | 135.46 | 114.21 | 77.42 | 84.35 |
Cash Income Tax Paid | 1.99 | 9.76 | 7.25 | 7.81 | 7.55 |
Change in Working Capital | 30.25 | 26.39 | -15.2 | -223.79 | -5.61 |